Erdheim-Chester disease (ECD) was first reported by J. Erdheim and W. Chester, in 1930. There are less than 250 reported cases till date. We report a case of ECD in a 16-year-old Malay male, who initially presented with elusive anemic symptoms with more specific symptoms of bony pain, cardiorespiratory and hepatic involvement evolving as the disease progressed.
Four months ago, patient was readmitted with severe anemic symptoms and bony pain in the limbs. He also had a distended painful abdomen. On general examination, patient was cachexic and abdominal examination revealed presence of ascites. There was no evidence of central nervous system involvement.
On investigation, plain chest X-ray showed cardiomegaly and Echo studies of the heart revealed poor left ventricular systolic function with ejection fraction of 26%. In addition to the global hypokinesia, there was a dilated left ventricle and a mild tricuspid regurgitation with EPASP of 30mmHg.
The results of laboratory tests showed low haemoglobin levels, markedly raised C-reactive protein and ESR levels and low serum albumin levels. Urine for Bence-Jones protein was negative. Plasma protein electrophoresis was normal. (Table I) Peripheral blood smear was suggestive of iron deficiency anemia with no lymphoma/ leukemic cells seen.
Plain X-ray of upper and lower limbs showed multiple sclerotic and lytic lesions over the metaphyseal regions of both humeri, femur and tibia (Fig 1) . The radiologist considered the lesions to be more likely suggestive of leukemia, with infiltrative metastasis to be ruled out. Ultrasound of the abdomen shows features suggestive of leukemic infiltration of liver and kidney.
An endoscopic liver biopsy was inconclusive. A trephine biopsy of the right tibial metaphysis was reported as sheets of foamy histiocytes between bony trabculae that were CD68 negative with S-100 protein with markedly reduced normal haemopoeitic marrow precursor cells and no obvious malignant cells (Fig 2) .
Patient was then referred to Hematology unit for further management. A course of intravenous corticosteroid showed some improvement in the bony pain and liver size. However chemotherapy/interferon-α could not be initiated as planned due to recurrent septicemia and respiratory failure and he succumbed after four months of diagnosis.
DISCUSSION
Erdheim-Chester disease (ECD) or polyostotic sclerosing histiocytosis is a non familial xanthogranulomatous, systemic histocytosis with unknown aetiology and pathogenesis that predominantly affects the bone and viscera 1 . The age of presentation ranges from 7 -84 years with a male-to-female ratio of 1:3. The varied presentation of the disease adds to the delay in diagnosis. 3 and infiltration of the skin leads to Xanthomas. Involvement of the liver and lymph nodes has not been consistently quoted in literature.
Several differential diagnoses become possible based on presenting feature, necessitating a battery of investigations. Metabolic and endocrinal disorders, malignancies, multiple sclerosis, thyroid abnormalities are some of the differential diagnoses that are considered.
Radiological features have been consistent and useful in diagnosis. Bilateral patchy or diffuse increase in density of the involved areas with coarsened trabecular pattern and minor changes, or sparing of the epiphysis is commonly seen. MRI is useful with involvement of the brain and bone where typical changes are noted 2 .
Elisa Dion et al. noted bilateral and symmetric osteosclerosis of the diaphysis of the long bones present in 98% of the visible lesion in the bone 4 .
Organ biopsies have been frequently inconclusive 2 . Bone biopsy is the gold standard in diagnosis. The typical histology of such bone lesions is described to be showing infiltration by clusters of lipid laden or foamy histocytes with chronic infiltration and Touton-type giant cells, usually surrounded by fibrosis and possibly fat necrosis 3 . Further, the histiocytes are typically, CD68 positive, CD1a negative and have variable expression for S-100 protein 3 with absent Birbeck granules. The histiocytes are also said to be Factor XIIIa positive 5 .
ECD as a reactive or neoplastic process has been debated. Vencio EF et al. 1 supported some cases of ECD to be clonal neoplastic disorders of putative histiocytic differentiation.
The treatment of ECD consists of surgical debulking, high dose corticosteroid therapy, cyclosporine, and radiation therapy and interferon-α therapy. However more research is necessary to prove the efficacy of the therapy.
In the present case, the infrequent age of presentation, involvement of organs (liver and lymph nodes), interpretation of the X-rays and ultrasound of abdomen (reported to be more suggestive of leukemia or metastasis), inconclusive liver biopsy, uncommon tricuspid valve involvement and ventricular hypertrophy were some of the parameters that led to the delay in diagnosis that is often associated with this condition.
Prognosis of the disease is poor and mortality is high due to associated complications.
